...
...
[

merck news

]

Indian firm launches Merck’s Covid pill under brand name ‘molulife’

A health worker administers Covid-19 vaccine to a beneficiary at Chembur Vaccination center in Mumbai on Wednesday. (Satish Bate/HT Photo)
Updated on Dec 30, 2021 04:31 AM IST

UK planning to rollout Merck's anti-Covid pill as soon as Christmas: Report

Merck’s antiviral pill was found to be 30% effective at reducing risk of hospitalization and death in high-risk people.
Published on Dec 05, 2021 03:26 PM IST

US panel backs Merck's first-of-a-kind Covid-19 pill 

The pill is already authorized in the UK.
Updated on Dec 01, 2021 10:45 AM IST

Merck asks EU drug regulator to authorise its Covid-19 pill

EMA said the drug should be given as soon as possible after Covid-19 has been diagnosed and within five days of symptoms starting.
Updated on Nov 24, 2021 12:20 AM IST

UK becomes first country to approve Merck's  anti-Covid pill molnupiravir

Based on the clinical trial data, the drug is most effective when taken during the early stages of infection and the MHRA recommends that it be used within five days of the onset of symptoms.
Published on Nov 04, 2021 05:31 PM IST

Experts laud Merck's Covid-19 drug molnupiravir. All you need to know

The experimental drug, molnupiravir, significantly reduced the risk of hospitalization or death when administered to high-risk patients early in the disease, Merck and its partner Ridgeback Biotherapeutics said in a statement.
Published on Oct 02, 2021 08:17 PM IST

Merck to help make Johnson & Johnson's single-shot Covid-19 vaccine: Report

The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, US.
Published on Mar 02, 2021 07:29 PM IST